Product comparison

Romy-500 Injection 1 ml belongs to the class of 'platelet-stimulating agents' primarily used to treat chronic immune thrombocytopenia in adults who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy. Immune thrombocytopenia, often called idiopathic thrombocytopenic purpura (ITP), is an immune disorder characterised by low platelet counts.

Romy-500 Injection 1 ml contains 'Romiplostim,' which is a thrombopoietin receptor agonist that functions similarly to thrombopoietin. Romy-500 Injection 1 ml promotes platelet formation by activating the thrombopoietin receptor. Thereby, Romy-500 Injection 1 ml helps treat immune thrombocytopenia effectively.

Romy-500 Injection 1 ml will be administered by the healthcare professional. In some cases, Romy-500 Injection 1 ml may cause common side effects like headache, joint pain, dizziness, trouble sleeping, muscle tenderness or weakness, pain in the arms and legs and indigestion. These side effects may vary individually. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.

Notify your doctor if you have allergic reactions to Romy-500 Injection 1 ml or other medications. You must inform your doctor if you have leukaemia (blood or bone marrow cancer), bleeding or clotting disorders, or heart, kidney, or liver problems. Romy-500 Injection 1 ml is not recommended during pregnancy unless indicated by the doctor. Romy-500 Injection 1 ml may make you dizzy; hence drive or operate machinery only when you are alert. Romy-500 Injection 1 ml is not recommended for use during breastfeeding.

Treatment of Immune thrombocytopenia or idiopathic thrombocytopenic purpura (ITP)

Romy-500 Injection 1 ml will be administered by a healthcare professional. Your doctor decides the dose and duration based on your medical condition and response to the treatment.

Romy-500 Injection 1 ml contains 'Romiplostim' which belongs to the class of 'thrombopoietin receptor agonists' used to treat low blood platelet count in patients with immune thrombocytopenia. Romy-500 Injection 1 ml promotes platelet formation by activating the thrombopoietin receptor. Thereby, Romy-500 Injection 1 ml helps treat immune thrombocytopenia effectively.

Romy-500 Injection 1 ml contains 'Romiplostim,' which is a thrombopoietin receptor agonist that functions similarly to thrombopoietin. Romy-500 Injection 1 ml promotes platelet formation by activating the thrombopoietin receptor. Thereby, Romy-500 Injection 1 ml helps treat immune thrombocytopenia effectively.

Store in a cool and dry place away from sunlight

In case of overdose, platelet count may increase resulting in thrombotic/thromboembolic complications. Since Romy-500 Injection 1 ml is administered by a healthcare professional, an overdose is unlikely to occur. However, seek medical attention if you experience any unusual symptoms.

Before beginning Romy-500 Injection 1 ml, notify your doctor if you have had any allergic reactions to Romy-500 Injection 1 ml or any other medications. You must notify your doctor if you have blood or bone marrow cancer (leukaemia), bleeding or clotting disorders, heart, kidney, or liver problems. Romy-500 Injection 1 ml is not recommended during pregnancy unless indicated by the doctor. Romy-500 Injection 1 ml may make you dizzy hence do not attempt to drive or operate machinery until you are physically stable and mentally alert. Romy-500 Injection 1 ml should never be used to normalize platelet counts; Romy-500 Injection 1 ml should only be used in ITP patients whose thrombocytopenia and clinical condition increase the risk of bleeding. Romy-500 Injection 1 ml is not recommended for use during breastfeeding.